BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 3910421)

  • 21. Standardization of the 32P-postlabeling assay for polycyclic aromatic hydrocarbon-DNA adducts.
    Shields PG; Harris CC; Petruzzelli S; Bowman ED; Weston A
    Mutagenesis; 1993 Mar; 8(2):121-6. PubMed ID: 8464380
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 32P-postlabeling of bile components: bulky adduct-like behavior in polyethyleneimine-cellulose thin layer chromatography.
    Vulimiri SV; Smith CV; Randerath E; Randerath K
    Carcinogenesis; 1994 Sep; 15(9):2061-4. PubMed ID: 7923604
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Storage phosphor imaging technique for detection and quantitation of DNA adducts measured by the 32P-postlabeling assay.
    Reichert WL; Stein JE; French B; Goodwin P; Varanasi U
    Carcinogenesis; 1992 Aug; 13(8):1475-9. PubMed ID: 1499099
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HPLC enrichment of hydrophobic DNA--carcinogen adducts for enhanced sensitivity of 32P-postlabeling analysis.
    Dunn BP; San RH
    Carcinogenesis; 1988 Jun; 9(6):1055-60. PubMed ID: 3286027
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis, characterization, and quantitation of a 4-aminobiphenyl-DNA adduct standard.
    Beland FA; Doerge DR; Churchwell MI; Poirier MC; Schoket B; Marques MM
    Chem Res Toxicol; 1999 Jan; 12(1):68-77. PubMed ID: 9894020
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of DNA modifications by the 32P-postlabelling assay.
    Phillips DH
    Mutat Res; 1997 Aug; 378(1-2):1-12. PubMed ID: 9288880
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methods for testing compounds for DNA adduct formation.
    Reddy MV
    Regul Toxicol Pharmacol; 2000 Dec; 32(3):256-63. PubMed ID: 11162719
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The 32P-postlabeling assay for DNA adducts.
    Phillips DH; Arlt VM
    Nat Protoc; 2007; 2(11):2772-81. PubMed ID: 18007613
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of carcinogen-DNA adducts in exfoliated urothelial cells of cigarette smokers: association with smoking, hemoglobin adducts, and urinary mutagenicity.
    Talaska G; Schamer M; Skipper P; Tannenbaum S; Caporaso N; Unruh L; Kadlubar FF; Bartsch H; Malaveille C; Vineis P
    Cancer Epidemiol Biomarkers Prev; 1991; 1(1):61-6. PubMed ID: 1845172
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 32P-Postlabeling of N-(deoxyguanosin-8-yl)arylamine adducts: a comparative study of labeling efficiencies.
    Mourato LL; Beland FA; Marques MM
    Chem Res Toxicol; 1999 Jul; 12(7):661-9. PubMed ID: 10409407
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exogenous and endogenous DNA modifications as monitored by 32P-postlabeling: relationships to cancer and aging.
    Randerath K; Li D; Nath R; Randerath E
    Exp Gerontol; 1992; 27(5-6):533-49. PubMed ID: 1426086
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 32P-postlabeling analysis of adducts formed from 1-phenylazo-2-hydroxynaphthalene (Sudan I, Solvent Yellow 14) with DNA and homopolydeoxyribonucleotides.
    Stiborová M; Frei E; Schmeiser HH; Wiessler M
    Carcinogenesis; 1992 Jul; 13(7):1221-5. PubMed ID: 1638690
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lung DNA adducts detected in human smokers are unrelated to typical polyaromatic carcinogens.
    Arif JM; Dresler C; Clapper ML; Gairola CG; Srinivasan C; Lubet RA; Gupta RC
    Chem Res Toxicol; 2006 Feb; 19(2):295-9. PubMed ID: 16485906
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influences of DNA isolation and RNA contamination on carcinogen-DNA adduct analysis by 32P-postlabeling.
    Godschalk RW; Maas LM; Kleinjans JC; Van Schooten FJ
    Environ Mol Mutagen; 1998; 32(4):344-50. PubMed ID: 9882009
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 32P-postlabeling detection of DNA adducts in fish from chemically contaminated waterways.
    Maccubbin AE; Black JJ; Dunn BP
    Sci Total Environ; 1990 May; 94(1-2):89-104. PubMed ID: 2193397
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tamoxifen-DNA adduct formation in rat liver determined by immunoassay and 32P-postlabeling.
    Divi RL; Osborne MR; Hewer A; Phillips DH; Poirier MC
    Cancer Res; 1999 Oct; 59(19):4829-33. PubMed ID: 10519392
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification and quantitation of hepatic DNA adducts formed in B6C3F1 mice from 1'-hydroxy-2',3'-dehydroestragole: comparison of the adducts detected with the 1'-3H-labelled carcinogen and by 32P-postlabelling.
    Fennell TR; Juhl U; Miller EC; Miller JA
    Carcinogenesis; 1986 Nov; 7(11):1881-7. PubMed ID: 3769137
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 32P-postlabeling analysis of DNA adducts from non-alternant PAH using thin-layer and high performance liquid chromatography.
    Weyand EH; Rice JE; LaVoie EJ
    Cancer Lett; 1987 Nov; 37(3):257-66. PubMed ID: 3677058
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 32P-postlabeling analysis of DNA adducts in liver of wild English sole (Parophrys vetulus) and winter flounder (Pseudopleuronectes americanus).
    Varanasi U; Reichert WL; Stein JE
    Cancer Res; 1989 Mar; 49(5):1171-7. PubMed ID: 2917348
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis, characterization, and 32P-postlabeling of N-(deoxyguanosin)-4-aminobiphenyl 3'-phosphate adducts.
    Haack T; Boche G; Kliem C; Wiessler M; Albert D; Schmeiser HH
    Chem Res Toxicol; 2004 Jun; 17(6):776-84. PubMed ID: 15206898
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.